Health Services Center, Ehime University, Bunkyo,Matsuyama, Ehime, 790-8577, Japan.
Department of Internal Medicine, Saiseikai Matsuyama Hospital, Matsuyama, Ehime, 791-8026, Japan.
BMC Gastroenterol. 2020 Nov 16;20(1):384. doi: 10.1186/s12876-020-01538-y.
Mucosal healing (MH) has been indicated as the therapeutic goal for ulcerative colitis (UC). Platelet count is known as an inflammation evaluation. However, the association between platelet count and MH among patients with UC is still scarce. We therefore assessed this issue among Japanese patients with UC.
The study subjects consisted of 345 Japanese patients with UC. Platelet count was divided into quartiles on the basis of the distribution of all study subjects (low, moderate, high, and very high). Several endoscope specialists were responsible for evaluating MH and partial MH, which was defined as a Mayo endoscopic subscore of 0 and 0-1, respectively. Estimations of crude odds ratios (ORs) and their 95% confidence intervals (CIs) for partial MH and MH in relation to platelet count were performed using logistic regression analysis. Age, sex, CRP, steroid use, and anti-Tumor necrosis factor α (TNFα) preparation were selected a priori as potential confounding factors.
The percentage of partial MH and MH were 63.2 and 26.1%, respectively. Moderate and very high was independently inversely associated with partial MH (moderate: OR 0.40 [95%CI 0.19-0.810], very high: OR 0.37 [95%CI 0.17-0.77], p for trend = 0.034). Similarly, moderate, high, and very high were independently inversely associated with MH (moderate: OR 0.37 [95% CI 0.18-0.73], high: OR 0.41 [95% CI 0.19-0.83], and very high: OR 0.45 [95% CI 0.21-0.94], p for trend = 0.033) after adjustment for confounding factors.
Among patients with UC, platelet count was independently inversely associated with MH.
黏膜愈合(MH)已被确定为溃疡性结肠炎(UC)的治疗目标。血小板计数是一种炎症评估指标。然而,UC 患者的血小板计数与 MH 之间的关系仍知之甚少。因此,我们评估了日本 UC 患者中的这一问题。
本研究共纳入 345 例日本 UC 患者。根据所有研究对象的分布,将血小板计数分为四等份(低、中、高和极高)。几位内镜专家负责评估 MH 和部分 MH,后者定义为 Mayo 内镜评分分别为 0 和 0-1。使用 logistic 回归分析评估血小板计数与部分 MH 和 MH 相关的粗比值比(OR)及其 95%置信区间(CI)。年龄、性别、CRP、皮质类固醇的使用以及抗肿瘤坏死因子-α(TNFα)制剂被预先选择为潜在的混杂因素。
部分 MH 和 MH 的百分比分别为 63.2%和 26.1%。中值和极高值与部分 MH 呈独立负相关(中值:OR 0.40 [95%CI 0.19-0.810],极高值:OR 0.37 [95%CI 0.17-0.77],趋势检验 P=0.034)。同样,中值、高值和极高值与 MH 呈独立负相关(中值:OR 0.37 [95%CI 0.18-0.73],高值:OR 0.41 [95%CI 0.19-0.83],极高值:OR 0.45 [95%CI 0.21-0.94],趋势检验 P=0.033),校正混杂因素后。
在 UC 患者中,血小板计数与 MH 呈独立负相关。